Opinion: Stop Private Speculation in COVID-19 Research

We present an economic plan for a collective sharing of scientific knowledge on the pandemic.

| 3 min read
coronavirus covid-19 sars-cov-2 economic patents shared open access research vaccine development

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, ANYAIVANOVA

The crisis triggered by the emergence of the SARS-CoV-2 coronavirus requires immediate leaps forward in economic policy strategies. In a document published in the Financial Times on March 13 we have underlined the urgency of international coordination to implement an immediate “anti-virus” plan in three points: immediate control of capital markets to counter speculation, public investments in health care and research, and interventions to remedy possible “disorganization” in the markets that could create bottlenecks in production and difficulties in supplying goods and services even beyond the health care sector.

Sharing scientific and technical knowledge publicly means winning the battle against the virus.

One aspect of this public planning seems particularly urgent to us. It is necessary to denounce the behavior of private agents driven by a profit motive who are causing slowdowns in research against the virus. There are private companies that announce impending discoveries in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Emiliano Brancaccio

    This person does not yet have a bio.
  • Ugo Pagano

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo